The presence of demyelination in the MI-control and MI-neb1 groups, but its absence in the MI-neb2 and sham-control groups, suggests that axonal damage after MI persisted, especially in the oral nebivolol group, although parenteral nebivolol may have suppressed this process. This evidence concerns the gene CPSF4 and myocardial infarction.